We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BIT market cap is 49.63M. The company's latest EPS is AUD -0.0039 and P/E is -12.82.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.07M | 803k | 1.46M | 1.56M | 1.43M |
| Operating Income | -1.7M | -3.64M | -3.2M | -2.78M | -3.61M |
| Net Income | -1.61M | -3.58M | -3.19M | -2.78M | -3.49M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.86M | 7.83M | 4.33M | 1.91M | 4.14M |
| Total Liabilities | 418k | 853k | 464k | 814k | 963k |
| Total Equity | 5.44M | 6.97M | 3.86M | 1.09M | 3.17M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.5M | -3.08M | -3.41M | -2.44M | -3.29M |
| Investing | -53k | N/A | -6k | N/A | N/A |
| Financing | 5.75M | 5M | -37k | -33k | 5.53M |
| Market Cap | 49.63M |
| Price to Earnings Ratio | -12.82 |
| Price to Sales Ratio | 31.25 |
| Price to Cash Ratio | 11.36 |
| Price to Book Ratio | 14.22 |
| Dividend Yield | - |
| Shares Outstanding | 902.28M |
| Average Volume (1 week) | 977.03k |
| Average Volume (1 Month) | 1.38M |
| 52 Week Change | 83.33% |
| 52 Week High | 0.125 |
| 52 Week Low | 0.024 |
| Spread (Intraday) | 0 (1.75%) |
| Company Name | Biotron Limited |
| Address |
level 2 sydney, new south wales 2000 |
| Website | https://www.biotron.com.au |
| Industry | diagnostic pharmaceutical (H3) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
